Pilot Immunotherapy Trial for Recurrent Malignant Gliomas

NCT01550523 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Malignant Glioma of Brain

Interventions

DRUG: IGF-1R/AS ODN
DEVICE: biodiffusion chamber

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University